|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||74.90 - 75.24|
|52 Week Range||57.72 - 75.48|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.09%|
It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.
On June 19, 2017, Melinta Therapeutics announced that its drug, Baxdela, had secured regulatory approval from the FDA as a treatment option for adult patients suffering from acute bacterial skin and skin ...
Ligand Pharmaceuticals (LGND) receives royalties from Novartis on Promacta’s sales according to a tiered annual payment structure.
In 2Q17, Ligand Pharmaceuticals (LGND) reported revenues of ~$28.0 million, representing year-over-year growth of ~43.4%. LGND received ~$14.2 million in royalties, a year-over-year rise of 45.7%.
One of the most vexing scenarios facing investors this year has been the ongoing disappointment delivered by U.S. small-caps and the corresponding exchange-traded funds. For instance, the iShares Russell ...
Flotek stock will likely close between $6.42 and $5.50 in the next seven days. Flotek's stock price was $5.96 on August 10, 2017.
Late July, I recommended going large in small-caps in the ETF Focus column. So far it hasn't worked. However, the iShares Core S&P Small-Cap ETF (IJR) and the iShares Russell 2000 ETF (IWM) are beating ...
Flotek Industries’ (FTK) management expressed optimism about improving pricing for FTK’s complex nano-Fluid (or CnF) products despite higher raw material costs.
U.S. small caps have been laggards for essentially all of this year, but the current state of affairs for smaller U.S. stocks is getting downright troubling. While large-cap indexes, such as the Dow Jones ...
If you're not ready to dive into an individual stock you can still get exposure to attractive corners of the market with index funds and we've picked three of our favorites.
On July 3, 2017, Flotek’s (FTK) implied volatility was ~58%. Since its 1Q17 earnings were announced on May 3, 2017, FTK's implied volatility has remained unchanged.
In 1Q17, Flotek Industries’ (FTK) total debt fell ~19% on a YoY basis. Its cash and marketable securities fell 26% during the same period.
Flotek's management expects an optimum recovery in energy reservoirs by upstream operators, which has already started to push demand for FTK’s technology.
IMN and Ritholtz Wealth Management’s Evidence-Based Investing Conference (West) is June 25-27 in Dana Point, California. Paul Kim, Principal Global Investors’ head of ETF strategy, will be on one of the first panels of the conference.
With arrival of spring comes first-quarter earnings announcements throughout the stock market. Large-cap companies generally report a little earlier, business results are better than 1Q's GDP might imply, and the news so far for both small- and ...